Rezolute Reports Q1 FY27 Results & Updates on upsLIFT
Rezolute reports Q1 FY27 financial results and business update. Enrollment is complete for the Phase 3 upsLIFT study with topline results expected in December, while the FDA recommended filing a BLA for congenital HI.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed